AZO
48
3
ZBH
59
2
AAP
30
3
LEG
28
6
MSI
63
3
D
40
-5
SHW
65
9
AMGN
47
8
XOM
42
5
GWW
64
-3
C
50
-4
LYB
37
12
CMCSA
59
6
AAL
48
6
NOV
52
3
DG
29
2
EQT
30
-9
MPC
28
2
STI
19
-21
FDX
30
-9
AZO
48
3
ZBH
59
2
AAP
30
3
LEG
28
6
MSI
63
3
D
40
-5
SHW
65
9
AMGN
47
8
XOM
42
5
GWW
64
-3
C
50
-4
LYB
37
12
CMCSA
59
6
AAL
48
6
NOV
52
3
DG
29
2
EQT
30
-9
MPC
28
2
STI
19
-21
FDX
30
-9
Financhill
Back

Regencell Bioscience Holdings 10K Form

Buy
64

RGC
Regencell Bioscience Holdings

Last Price:
7.65
Seasonality Move:
27.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.63
Price / Book: 12.38

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-4.3M
Gross Margin: $1.97B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Buy
64
Regencell Bioscience Holdings (RGC) is a Buy

Is Regencell Bioscience Holdings a Buy or a Sell?